On March 1, 2025, in the United States, Natural Dior LLC voluntarily recalled Vitafer-L Gold Liquid dietary supplement for undeclared presence of tadalafil. This drug is not acknowledged by dietary supplement because it is a prescription drug for erectile dysfunction. The presence of tadalafil may pose health-damage risks to individuals with pre-existing medical conditions or patients taking nitrates in such products. [1]

Natural Dior LLC Issues Recall of Vitafer-L Gold Liquid – March 2025

Recall , May 15, 2025

On March 1, 2025, in the United States, Natural Dior LLC voluntarily recalled Vitafer-L Gold Liquid dietary supplement for undeclared presence of tadalafil. This drug is not acknowledged by dietary supplement because it is a prescription drug for erectile dysfunction. The presence of tadalafil may pose health-damage risks to individuals with pre-existing medical conditions or patients taking nitrates in such products. [1]

Reason Behind the Recall

This was not stated on the packaging and indicates some intense adverse effects, probably with risky hypotension when used with nitrate medicine. This is intended for consumers’ health preservation against these dangers. It failed the FDA criteria for labeling active drug ingredients in products, hence having to recall this product. [2]

Root Cause Analysis

The manufacturer failed to properly classify the active ingredients under the respective regulations and did not validate the purity of the active ingredients before marketing. This is a major compliance violation resulting from the lack of a pharmacological activity test and lack of declaration for the presence of tadalafil in the product. The assessment of raw materials by a third party and Good Manufacturing Practices (GMP) audit were not performed. [3]

Product Description

  • Brand: ONatural Dior LLC
  • Product: Vitafer-L Gold Liquid
  • Size: Liquid Bottle
  • Issue: Tadalafil Undeclared presence.
  • Lot Numbers and Expiry Dates:
  1. Lot 7021-2304 – Expiring April 2025
  2. Lot 7017-2304 – Expiring April 2025
  3. Lot 7040-2305 – Expiring May 2025
  4. Lot 10020-2402 – Expiring February 2026
  5. Lot 10011-2404 – Expiring April 2026
  6. Lot 7695-2307 – Expiration Not Given
  7. Lot R6715-2303 – Expiring March 2025
  8. Lot 7292-2305 – Expiring May 2025
  9. Lot 9669-2403 – Expiring March 2025
  10. Lot 10060-2404 – Expiring April 2026 [4]

Issue Identified

The product was found to contain tadalafil, a prescription drug that had not been declared on the product’s ingredient list or allergen panel. Hence making such an act an immediate serious violation concerning the dietary supplement regulations. Thus, the product was immediately recalled from retail and online sites. [5]

Natural Dior LLC Issues Recall of Vitafer-L Gold Liquid-FRL

Regulatory Body Concerns

  • According to the FDA, the undisclosed presence of tadalafil constituted a major issue vis-a-vis the Food, Drug, and Cosmetic Act (FD&C Act).
  • The FDA considers the presence of prescription drugs in dietary supplements as adulteration.
  • Recall was conducted under the FDA’s direction to protect consumers from possible health risks stemming from unlisted pharmaceutical ingredients. [2]

Manufacturer’s Consumer Guidance

Natural Dior LLC issued guidance to consumers:

 

  • The purchaser must discontinue the use of Vitafer-L Gold Liquid.
  • Consumers are advised to contact Natural Dior LLC customer services for refunds or exchanges.
  • Inform adverse effects to a healthcare provider or FDA MedWatch.
  • The manufacturer intends to strengthen its procedures for ingredient verification and product labeling in the future. [6]

FRL Commentary

This recall highlights the necessity for dietary supplement companies to adhere strictly to regulatory requirements.

FRL advises nutraceutical companies to:

  • Establish proper ingredient validation and testing.
  • Comply with FDA requirements for accurate ingredient labeling and premarket product approval.
  • Engage a third party to test for unapproved drugs and pharmaceutical substances.

Concluding Remarks

This recall emphasizes the emergency of sufficient ingredient verification and regulatory compliance. Nutraceutical brands should comply with FDA guidelines not to become contaminated with unapproved drugs and protect consumer health and trust.